Orin
LHXNYSE·Aerospace & Defense

L3Harris Technologies, Inc.

Market cap $48.3BP/E 26.0× trailingGross margin 25.5%
$259.40
−0.83 (−0.32%)Tue 27 Oct close 16:00 ET
52-wk $232.34 – $379.23
Orin's take
6out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 9 Oct, the 9th take on LHX. A new filing or a print queues the next refresh.

L3Harris shows accelerating top-line momentum — Q1 and Q2 FY2026 revenue grew 11.9% and 8.4% YoY respectively, with eight consecutive EPS beats including a 11.8% surprise in Q2 — and just secured a $6B THAAD propulsion contract that underscores strong defense demand.

However, gross margin has compressed from 30.2% in FY2021 to 25.7% in FY2025, the stock trades at $236.92, well below both its 50-day MA of $259.92 and 200-day MA of $309.67, and Pomerantz LLP has issued multiple securities investigation notices in September–October 2026. With valuation reasonable (PE of 23.79, a 6.1% discount to peer median) but technicals broken and legal overhang unresolved, patience is warranted until the investigation clarifies and the downtrend reverses.

What could go wrong

  • Securities investigations. Pomerantz LLP has issued at least four investor-alert announcements between September 24 and October 6, 2026, investigating claims on behalf of LHX shareholders; outcome and scope remain unknown.
  • Margin compression. Gross margin has declined every year from 30.2% (FY2021) to 25.7% (FY2025), and operating margin sits at 9.8% versus 11.8% in FY2021, suggesting cost or mix headwinds despite revenue growth.
  • Downtrend persistence. Stock at $236.92 is below both MA50 ($259.92) and MA200 ($309.67) as of October 8, 2026; RSI at 33.47 indicates oversold conditions but no confirmed reversal signal.
  • Insider dispositions. Over the trailing 24 months, insiders recorded 12 dispositions and 0 open-market acquisitions, with net shares sold of 265,607 valued at $73.9M.

What would change my mind

Investigation resolution. Pomerantz investigation is closed, dismissed, or resolved without material findings, removing legal overhangbullish
Margin stabilization. Gross margin stops declining and shows sequential improvement in Q3 or Q4 FY2026 quarterly resultsbullish
Technical reclaim. Stock closes above the 50-day MA (~$260) on increasing volume, confirming trend reversal from oversold levelsbullish
Investigation escalation. A class-action lawsuit is filed or regulatory body opens a formal probe stemming from the Pomerantz investigationbearish

Where this comes from: Q1–Q2 FY26 results · earnings vs estimates · news, 29 Sep · FY21 and FY25 fundamentals. Orin's read on LHX; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Down 10.9% over twelve months, from $291.14 on 27 Oct 2025 to $259.40 at the Tue 27 Oct 2026 close. Its highest close in that time was $378.48 on 2 Mar 2026; the last close is 31.5% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 4.7M, on 13 Jan 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    BlackRock$5.5B0.1%
    Vanguard Capital Management$3.5B0.1%
    Vanguard Portfolio Management$2.8B0.1%
    State Street$2.6B0.1%
    Capital World Investors$1.9B0.2%
    Geode Capital Management$1.5B0.1%
    Wellington Management Group$1.4B0.2%
    Wells Fargo$1.3B0.2%
    Morgan Stanley$1.1B0.1%
    T. Rowe Price Associates$957.4M0.1%

    114 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 129 Form 4 filings; open-market trades net −$73.9M. Of the 50 on hand, 0 were open-market purchases and 4 sales — the rest are grants, option exercises and tax withholding.

    Ask Orin about LHX

    its filings · its transcripts · its numbers

    Orin answers questions about LHX from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 26.0× its last 12 months of profit (Tue 27 Oct close) — higher than in 1 of its last 5 fiscal years (middle 32.6×); the typical Industrials company on the NYSE is at 33.7×.

    MeasureNowIts usualSector
    P/E26.0×below usual32.6×33.7×
    P/S2.11×below usual2.34×—
    EV/EBITDA14.5×below usual17.9×—
    P/B2.3×above usual2.2×—
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    13 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $340 (from $315 to $365) — 31% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $340

    $315 – $365 · +31% against the last close

    Their ratings
    • 10 buy or overweight
    • 3 hold
    • 0 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    middle P/E 22.0× · 7 of 7 with a profit

    Priced at 26.0× its last 12 months of profit; the middle P/E of the 7 companies it is compared to that made a profit is 22.0×.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    LHXL3Harris Technologies, Inc.$48B26.0×14.5×25.5%8.2%9%
    DRSLeonardo DRS, Inc.$10B30.0×19.4×24.9%8.5%12%
    GDGeneral Dynamics Corporation$96B21.3×15.1×15.4%8.2%17%
    KTOSKratos Defense & Security Solutions, Inc.$6B276×58.7×22.1%1.3%1%
    LDOSLeidos Holdings, Inc.$18B12.9×9.9×17.4%7.9%28%
    LMTLockheed Martin Corporation$144B22.0×15.1×11.7%8.2%79%
    NOCNorthrop Grumman Corporation$78B17.4×12.3×20.0%10.4%26%
    RTXRTX Corporation$263B31.2×17.4×21.1%8.9%13%
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 26.0× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now26.0×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Industrials companies on the NYSE were priced at a typical 33.7× their yearly profit (Tue 27 Oct close).

    • Now33.7×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $259.32

    A standard cash-flow model puts it at $271 a share — 4% above the $259.32 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$2714% above $259.32
    Levered$21019% below $259.32

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.